More mutations, better annotations The Fall 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the…

  Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. These tumors can develop anywhere…

QIAGEN collaborates with a team from the University of Munich by applying bioinformatics software tools OmicSoft ArrayStudio and Ingenuity Pathway Analysis (IPA) to discover progranulin as a novel and sensitive biomarker for sepsis.

Analysis of microbiome transcriptomes In our recent white paper we describe how to investigate the functional potential of a microbial…

Researchers across the world are using Ingenuity Pathway Analysis to accelerate their work in a variety of applications, including the…

New visualizations for diversity When investigating the composition of microbial communities, researchers often need to calculate and visualize the diversity…

Functional metagenomics analysis of environmental microbiomes: A new white paper for the Microbial Genomics Module of CLC Genomics Workbench Microbiome…

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now available…

We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over…

QIAseq Expanded Carrier Screening Panel and industry-leading software identify genetic variants responsible for more than 200 disease indications Every year,…

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…